Modulation of Bacillus subtilis catabolite repression by transition state regulatory protein AbrB.
The first enzyme of the Bacillus subtilis histidine-degradative (hut) pathway, histidase, was expressed at higher levels during the onset of the stationary growth phase in nutrient sporulation medium in early-blocked sporulation mutants (spo0A) than in wild-type strains. Histidase expression was also elevated in spo0A mutant cultures compared with wild-type cultures during the logarithmic growth phase in minimal medium containing slowly metabolized carbon sources. Histidase expression was not derepressed in spo0A abrB mutant cultures under these growth conditions, suggesting that the AbrB protein is responsible for the derepression of histidase synthesis seen in spo0A mutant cultures. spo0A mutants contain higher levels of the AbrB protein than do wild-type strains because the Spo0A protein represses AbrB expression. A direct correlation between the levels of abrB transcription and histidase expression was found in spo0A mutant cultures. The hutOCR2 operator, which is required for wild-type regulation of hut expression by catabolite repression, was also required for AbrB-dependent derepression of hut expression in spo0A mutants. Purified AbrB protein bound to the hutOCR2 operator in vitro, suggesting that AbrB protein alters hut expression by competing with the hut catabolite repressor protein for binding to the hutOCR2 site. During the logarithmic growth phase in media containing slowly metabolized carbon sources, the expression of several other enzymes subject to catabolite repression was elevated in spo0A mutants but not in spo0A abrB mutants. This suggests that the AbrB protein acts as a global modulator of catabolite repression during carbon-limited growth.
Fisher
S H
SH
Department of Microbiology, Boston University School of Medicine, Massachusetts 02118.
Strauch
M A
MA
Atkinson
M R
MR
Wray
L V
LV
D001089:Arabinose / Q000378:metabolism; D001412:Bacillus subtilis / Q000201:enzymology / Q000235:genetics* / Q000254:growth & development; D001426:Bacterial Proteins / Q000494:pharmacology*; D001483:Base Sequence; D001673:Biodegradation, Environmental; D002455:Cell Division; D003470:Culture Media; D004268:DNA-Binding Proteins / Q000494:pharmacology*; D004794:Enzyme Repression / Q000187:drug effects*; D015964:Gene Expression Regulation, Bacterial; D005947:Glucose / Q000378:metabolism; D006639:Histidine / Q000378:metabolism; D006638:Histidine Ammonia-Lyase / Q000096:biosynthesis / Q000235:genetics; D008969:Molecular Sequence Data; D009154:Mutation; D009875:Operator Regions, Genetic; D011993:Recombinant Fusion Proteins / Q000096:biosynthesis; D014157:Transcription Factors / Q000494:pharmacology*; D001616:beta-Galactosidase / Q000096:biosynthesis / Q000235:genetics
C060762:AbrB protein, Bacillus subtilis; D001426:Bacterial Proteins; D003470:Culture Media; D004268:DNA-Binding Proteins; D011993:Recombinant Fusion Proteins; D014157:Transcription Factors; D006639:Histidine; D001089:Arabinose; D001616:beta-Galactosidase; D006638:Histidine Ammonia-Lyase; D005947:Glucose